Targeting translation in hypoxic tumors

David Ron1, Alan G Hinnebusch

  • 1Skirball Institute of Biomolecular Medicine and the Department of Medicine, New York University School of Medicine, New York, New York 10016, USA. ron@saturn.med.nyu.edu

ACS Chemical Biology
|December 14, 2006
PubMed

Insights

Mammalian cells adapt protein production to low oxygen (hypoxia) by altering their translational machinery. This offers potential to target tumor cells and influence physiological processes.

Area of Science:

  • Molecular Biology
  • Cellular Physiology
  • Cancer Biology

Background:

  • Mammalian cells possess complex regulatory networks controlling protein synthesis.
  • Hypoxic conditions, common in tumors, significantly alter cellular metabolism and function.
  • Understanding cellular adaptation to hypoxia is crucial for therapeutic development.

Purpose of the Study:

  • To explore the possibility of targeting the translational machinery in mammalian cells under hypoxic conditions.
  • To investigate the potential for selective inhibition of metabolically compromised tumor cells.
  • To assess the broader implications for manipulating physiological processes.

Main Methods:

  • Analysis of recent insights into mammalian cell translational machinery adaptation.
  • Review of regulatory networks involved in hypoxia response.
  • Exploration of therapeutic targeting strategies.

Main Results:

  • Recent findings reveal specific adaptations in the translational machinery of cells exposed to hypoxia.
  • These adaptations involve intricate regulatory networks that can be potentially targeted.
  • Selective inhibition of tumor cells with compromised metabolism is a plausible outcome.

Conclusions:

  • Targeting the hypoxia-induced translational machinery offers a promising strategy for cancer therapy.
  • This approach may allow for selective elimination of tumor cells while sparing normal tissues.
  • Further research could unlock broader applications in manipulating physiological processes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...